InChI=1S/C20H30O4/c1- 2- 18(21) 14- 11- 9- 7- 5- 3- 4- 6- 8- 10- 12- 15- 19(22) 16- 13- 17- 20(23) 24/h3- 4,7- 12,14- 15,18- 19,21- 22H,2,5- 6,13,16- 17H2,1H3,(H,23,24) /b4- 3- ,9- 7- ,10- 8- ,14- 11+,15- 12+/t18- ,19- /m1/s1 |
KPRHYAOSTOHNQA-NNQKPOSRSA-N |
C(C[C@@H](/C=C/C=C\C/C=C\C\C=C/C=C/[C@@H](CC)O)O)CC(=O)O |
|
Rattus norvegicus
(NCBI:txid10116)
|
See:
PubMed
|
Homo Sapiens
(NCBI:txid9606)
|
See:
PubMed
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
rat metabolite
Any mammalian metabolite produced during a metabolic reaction in rat (Rattus norvegicus).
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(5S,6E,8Z,11Z,14Z,16E,18R)- 5,18- dihydroxyicosa- 6,8,11,14,16- pentaenoic acid
|
5S,18R-Dihydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid
|
KEGG COMPOUND
|
RvE2
|
ChEBI
|
14339384
|
Reaxys Registry Number
|
Reaxys
|
17114001
|
PubMed citation
|
Europe PMC
|
19637859
|
PubMed citation
|
Europe PMC
|
21206090
|
PubMed citation
|
Europe PMC
|
22450811
|
PubMed citation
|
Europe PMC
|
22904297
|
PubMed citation
|
Europe PMC
|
26462421
|
PubMed citation
|
Europe PMC
|
26485038
|
PubMed citation
|
Europe PMC
|
27121596
|
PubMed citation
|
Europe PMC
|
27337457
|
PubMed citation
|
Europe PMC
|
|